Navamedic
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Navamedic is a Nordic pharmaceutical company that develops, produces, and commercializes medicines and related products. The company acts as a supplier of high-quality prescription drugs, consumer health goods, and hospital products, distributing them to hospitals and pharmacies. Its diverse portfolio includes branded generics and specialty pharmaceuticals targeting therapeutic areas such as obesity, Parkinson's disorder, inborn errors of metabolism, and addiction treatment. Recent product launches include Eroxon®, an over-the-counter topical treatment for erectile dysfunction. Navamedic also develops medical devices like OraFID®, a dispenser for precise quantities of minitablets.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Navamedic.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-28 15:19 |
Major Shareholding Notification
Flaggemelding
|
Norwegian | 465 bytes | |
| 2025-08-14 07:00 |
Investor Presentation
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025 - Attachment: Navam…
|
English | 2.8 MB | |
| 2025-08-14 07:00 |
Investor Presentation
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 - At…
|
English | 2.8 MB | |
| 2025-08-14 07:00 |
Interim Report
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025 - Attachment: Navam…
|
English | 836.1 KB | |
| 2025-08-14 07:00 |
Interim Report
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 - At…
|
English | 836.1 KB | |
| 2025-08-14 07:00 |
Earnings Release
Navamedic ASA: Rapport for 2. kvartal og første halvår 2025
|
Norwegian | 5.9 KB | |
| 2025-08-14 07:00 |
Earnings Release
Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
|
English | 5.9 KB | |
| 2025-08-13 09:51 |
Regulatory News Service
Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all No…
|
English | 2.9 KB | |
| 2025-08-11 13:03 |
Report Publication Announcement
Navamedic ASA: Invitation to 2025 2nd quarter presentation
|
English | 2.0 KB | |
| 2025-07-15 12:32 |
M&A Activity
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
|
English | 5.7 KB | |
| 2025-07-15 08:25 |
Pre-Annual General Meeting Information
Navamedic ASA: Ex. subscription rights today
|
English | 523 bytes | |
| 2025-07-14 15:27 |
Post-Annual General Meeting Information
Navamedic ASA - Minutes of Extraordinary General Meeting - Attachment: Navamedi…
|
Norwegian | 354.3 KB | |
| 2025-07-14 15:27 |
Post-Annual General Meeting Information
Navamedic ASA - Minutes of Extraordinary General Meeting
|
English | 1.0 KB | |
| 2025-07-11 14:16 |
Director's Dealing
Navamedic ASA: Mandatory notice of trade - Attachment: Notification_of_trade_JD…
|
Norwegian | 79.4 KB | |
| 2025-07-11 14:16 |
Director's Dealing
Navamedic ASA: Mandatory notice of trade
|
English | 862 bytes |
Automate Your Workflow. Get a real-time feed of all Navamedic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Navamedic via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
